Literature DB >> 26108407

Mutual interaction between BCL6 and miRNAs contributing to the pathogenesis of various cancers.

Z Wei1,2, W Gao1,3, Y Wu1, B Ni4, Y Tian5.   

Abstract

MicroRNA (miRNA), a class of non-protein-coding RNAs, plays a critical role in many cellular processes, such as invasion, proliferation and migration, and also function in disease pathology. The transcription factor and proto-oncogene B cell CLL/lymphoma 6 (BCL6) is aberrantly expressed in various cancers. An increasing body of evidence has demonstrated that miRNAs and BCL6 can target one another and mutually adjust their expression which are of great importance in the pathogenesis of various cancers. In this report, we summarize the mutual interaction between miRNAs and BCL6, which have been studied in cancers, highlighting their mechanisms and potential therapeutic targets in cancers.

Entities:  

Keywords:  BCL6; Cancer; Oncogene; miRNA

Mesh:

Substances:

Year:  2015        PMID: 26108407     DOI: 10.1007/s12094-015-1322-y

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  56 in total

1.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

2.  Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer.

Authors:  Dong-Xu He; Xiao-Ting Gu; You-Ran Li; Li Jiang; Jian Jin; Xin Ma
Journal:  FEBS J       Date:  2014-09-30       Impact factor: 5.542

3.  Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR.

Authors:  Stella Maris Ranuncolo; Jose M Polo; Jamil Dierov; Michael Singer; Tracy Kuo; John Greally; Roland Green; Martin Carroll; Ari Melnick
Journal:  Nat Immunol       Date:  2007-06-10       Impact factor: 25.606

Review 4.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

5.  Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT.

Authors:  Sunmi Seok; Dong-Hyun Kim; Sung-E Choi; Ting Fu; Eunkyung Yu; Kwan-Woo Lee; Yup Kang; Xiaoling Li; Byron Kemper; Jongsook Kim Kemper
Journal:  Aging Cell       Date:  2013-08-11       Impact factor: 9.304

6.  MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.

Authors:  Fen Du; Fang Yu; Yuzhen Wang; Yvonne Hui; Kevin Carnevale; Mingui Fu; Hong Lu; Daping Fan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-06       Impact factor: 8.311

Review 7.  Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.

Authors:  E D Cahir McFarland; K M Izumi; G Mosialos
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

8.  Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions.

Authors:  Mario Andres Blanco; Masa Alečković; Yuling Hua; Tuo Li; Yong Wei; Zhen Xu; Ileana M Cristea; Yibin Kang
Journal:  J Biol Chem       Date:  2011-04-08       Impact factor: 5.157

9.  MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages.

Authors:  Maliheh Nazari-Jahantigh; Yuanyuan Wei; Heidi Noels; Shamima Akhtar; Zhe Zhou; Rory R Koenen; Kathrin Heyll; Felix Gremse; Fabian Kiessling; Jochen Grommes; Christian Weber; Andreas Schober
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

10.  Inhibition of miR-25 improves cardiac contractility in the failing heart.

Authors:  Christine Wahlquist; Dongtak Jeong; Agustin Rojas-Muñoz; Changwon Kho; Ahyoung Lee; Shinichi Mitsuyama; Alain van Mil; Woo Jin Park; Joost P G Sluijter; Pieter A F Doevendans; Roger J Hajjar; Mark Mercola
Journal:  Nature       Date:  2014-03-12       Impact factor: 49.962

View more
  3 in total

1.  Bcl6 Suppresses Cardiac Fibroblast Activation and Function via Directly Binding to Smad4.

Authors:  Jian Ni; Qing-Qing Wu; Hai-Han Liao; Di Fan; Qi-Zhu Tang
Journal:  Curr Med Sci       Date:  2019-07-25

2.  The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.

Authors:  Richard E Kast; Nicolas Skuli; Samuel Cos; Georg Karpel-Massler; Yusuke Shiozawa; Ran Goshen; Marc-Eric Halatsch
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-07-11

3.  Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma.

Authors:  Kailiang Zhang; Chuan Dong; Ming Chen; Tongtao Yang; Xin Wang; Yongheng Gao; Lijuan Wang; Yanhua Wen; Guanyin Chen; Xinli Wang; Xiuchun Yu; Yinglong Zhang; Pingshan Wang; Mingfu Shang; Kang Han; Yong Zhou
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.